[1]
Wołowiec, Łukasz et al. 2024. Modulation of Inflammation in Heart Failure: The Role of Ziltivekimab and Canakinumab. Journal of Education, Health and Sport. 65, (Oct. 2024), 55579. DOI:https://doi.org/10.12775/JEHS.2024.65.55579.